Anhui Palo Alto Pharmaceuticals, Inc.
Clinical trials sponsored by Anhui Palo Alto Pharmaceuticals, Inc., explained in plain language.
-
New asthma inhaler shows promise in early trial
Disease control Recruiting nowThis study tests a new inhaled medicine called PA9159 for adults with asthma. The goal is to see if it safely improves lung function over 4 weeks. About 30 participants will use the inhaler and have their breathing measured. It is a phase 2 trial, meaning it is still in early tes…
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 08:24 UTC
-
New asthma inhaler shows promise in early trial
Disease control Recruiting nowThis study tests a new inhaled corticosteroid called PA9159 for adults with bronchial asthma. The goal is to see if it safely improves lung function over 4 weeks. About 60 participants will take the drug and have their breathing measured. This is a Phase 2 trial, meaning it's sti…
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 08:24 UTC